- BS Biology 1974, Massachusetts Institute of Technology, Cambridge, Massachusetts
- Lab Technician 1974-1976, Immunology Department. John Curtin School of Medical Research, Canberra, Australia
- MD Degree 1980; attended New Jersey Medical School 1976-78, attended University of Mississippi Medical School, 1978-80
- Birth of two children, 1980 and 1981, with part-time work as medical consultant for Social Security Disability, 1980-1982
- Internal Medicine Residency 1982-5, University of Mississippi Medical Center, Jackson, Mississippi
- Emergency Room Physician 1985-1999, Parkview Hospital, Brunswick ME (2 years), Wing Hospital, Palmer MA (10 years), Farren Hospital, Turners Falls MA (1 year) , Franklin Medical Center, Greenfield MA (1 year)
- Instructor, University of Massachusetts Medical School, Department of Internal Medicine, 1989-1993
- Internal Medicine Physician 1993, Kaiser Permanente, Amherst Massachusetts; 1999-2002 solo practitioner, Freeport, Maine
- Removal of spinal cord meningioma 2002, necessitating closure of my solo practice
- Internist and Hospitalist 2003-present, Mount Desert Island Hospital, Bar Harbor, Maine
- Listed since 2004 in Marquis’ “Who’s Who in America.” Listed since 2005 in “Who’s Who in the World.” Listed in 2006 in “Who’s Who in Medicine and Healthcare,” “Who’s Who in Science and Engineering” and “Who’s Who in American Women”
Author, Public Speaker, Expert Witness
world’s largest anthrax epizootic, in Zimbabwe, and showed its cause was
biological warfare. This was the first ever publication in which an epidemic
was analyzed scientifically to distinguish whether it was natural or
deliberately caused. Developed a model to assess epidemics for the
likelihood they are caused by biological warfare, 1989-1992; Dr. Nass’
investigation was discussed in a 1994 report on biological warfare by The
Royal Society, U.K. (http://www.royalsoc.ac.uk/document.asp?id=1886), in the 1999 book Plague
Wars by BBC Senior Correspondent Tom Mangold and Jeff Goldberg, and
in other books and articles.
for Cuban Ministry of Health on optic and peripheral neuropathy epidemic
affecting 50,000 Cubans; accurately diagnosed its cause as cyanide toxicity
in the setting of nutritional deficiency and assisted with investigation and
treatment regimens, 1993.
Federation of American Scientists Working Group on Investigation of Alleged
Use or Release of Biological or Toxin Weapons Agents. Coauthored a detailed
report for the 1996 Biological Weapons Convention Review Conference on how
to investigate allegations of biological warfare, 1994-1996. http://www.fas.org/bwc/papers/report.html
Produced two Congressional testimonies (for the
House Government Reform Committee http://www.anthraxvaccine.org/response.htm
and Senate HELP Subcommittee http://www.ahrp.org/testimonypresentations/NassBiodefense0205.php)
- Evaluated government-sponsored anthrax research in relation to military policy and Biological Weapons Convention norms, 1989-1991.
- Used anthrax as a model for discussion of how to prevent biological warfare, 1991-1992.
- Reviewed anthrax vaccines and other therapies to create a model for effective biological warfare prophylaxis, 1997-1999.
- Produced numerous reports, academic and popular articles, and spoke widely throughout the US to educate military servicemembers, Congress and the public about anthrax, the science underlying biological warfare prophylaxis and the range of available methods for responding to a bioterrorism threat. Produced testimonies at the requests of the House Subcommittee on National Security, the House Armed Services Committee, and the House Committee on Government Reform. Assisted Congressional staff in hearing preparations. Spoke before two Institute of Medicine committees: on Gulf War Illness exposures, and safety and efficacy of the anthrax vaccine. Critiqued the March 2002 Institute of Medicine Report on anthrax vaccine safety and efficacy. 1998-2005.
- Developed a range of recommendations for dealing with the anthrax domestic terrorism crisis as it unfolded, published on my website, and adopted by other authors, 2001.
- Quoted in the New York Times, Boston Globe, Wall Street Journal, Chicago Tribune, LA Times, USA Today, The Lancet, New Scientist and scores of other newspapers and journals, regarding anthrax attacks, anthrax vaccine, and preventing and responding to bioterrorism, 1990-present.
- Interviewed on all major US TV networks and scores of radio/TV programs in the US, Japan, France, Germany, Spain, Canada and Australia, 1998-present.
- Investigated the cause of chronic symptoms in survivors of inhalation anthrax; this problem was discussed on page A1 of the NY Times September 16, 2002.
written comments to the draft Joint Vaccine Acquisition Program
Environmental Impact Statement on proposal to use soldiers for vaccine
experiments without informed consent. (See
the Joint Vaccine Acquisition Program: Final
Programmatic Environmental Assessment. Joint Vaccine Acquisition Program
Project Management Office, Department of the Army, August 1997)
written comments to FDA and the House National Security Subcommittee on
Executive Order 13139, which created a new policy for military use of
unlicensed medical therapeutics without informed consent, 1999 http://www.anthraxvaccine.org/doc1.htm
popular and academic articles dealing with the use of unlicensed and expired
medical products in soldiers, and the conflicts of interest endemic to
military medicine, 1999-2004
the NIH-sponsored multi-center ARDSNet study of ventilator settings in ARDS
and acute lung injury, on the basis of: unethical enrollment without
informed consent, failure to apply the current standard of care in the
control arm, inability to diverge from the study protocol when patients
exhibited evidence of harm, poor experimental design that led to the
spurious claim that low-volume ventilation strategies should be adopted as
the new standard of care, and inadequate data safety monitoring.
The NIH’s Office of Human Research Protection subsequently halted
this trial, 2003 http://www.ahrp.org/testimonypresentations/ARDSNet0603/nass.html
the military collection of adverse event data, in which the rate of serious
side effects for smallpox vaccine in soldiers was only 14% as high as
determined by CDC for vaccinated civilians, 2003
Medical Letter, 1998-present
Accounting Office, 1998-9
Hospital Formulary Service 2002 Drug Information Yearbook, 2001
Development Bank, 2001
Opinion on Pharmacotherapy, 2002
SIPRI (Stockholm International Peace Research Institute) Yearbook, 2002
Unsolved Mysteries (television program), 2002
Opinion on Biological Therapy, 2003
of Clinical Pharmacology, 2006
of American Physicians and Surgeons, 2006
Advisory Board Member:
for Human Research Protection, New York, NY
Institute for Molecular Medicine, Huntington Beach, CA
National Vaccine Information Center, Vienna, VA
Military and Biodefense Vaccine Project, Vienna, VA
- Hearing, Senate HELP Subcommittee on Health and Bioterrorism, “Bioshield 2: Next Steps.” February 8, 2005. (Written). http://www.ahrp.org/testimonypresentations/NassBiodefense0205.php
- Hearing, Independent Inquiry on Gulf War Veterans’ Illnesses, September 1, 2004, “Anthrax Vaccine and Gulf War veterans’ illnesses.” London, England. (Written and oral) www.lloyd-gwii.com/admin/ManagedFiles/2/M%20Nass%20presentation%20for%20GWS%20inquiry,%20Sept%201%202004.doc
- Meeting, Office of Human Research Protection, Department of Health and Human Services. June 10, 2003. “Ethical and Scientific Concerns in an ARDS Network Trial.” (Written and oral) http://www.ahrp.org/testimonypresentations/ARDSNet0603/nass.html
- Joint Hearing, Massachusetts State Legislature. May 15, 2003. “Mandatory National Guard Vaccinations.” (Oral)
- Hearing, House Committee on Government Reform. November 14, 2001. “Preparing a Medical Response to Bioterrorism.” (Written) www.anthraxvaccine.org/response.htm
- Meeting, Institute of Medicine Committee on Anthrax Vaccine Safety and Efficacy. October 3, 2000. (Written and oral) http://www.anthraxvaccine.org/IOMtalk.htm
- Meeting, Institute of Medicine Committee on Health Effects Associated with Exposures During the Persian Gulf War. December 15, 1999. (Written and oral)
- Hearing, House Subcommittee on National Security, Veterans Affairs and International Relations. “Executive Order 13139: Strengthening Oversight of Investigational Products.” November 9, 1999. (Written) http://www.anthraxvaccine.org/doc1.htm
- Hearing, House Military Personnel Subcommittee. September 30, 1999. “Anthrax Vaccine Issues: Clearing the Air.” (Written) http://www.anthraxvaccine.org/Testimonies.html
- Hearing, House Subcommittee on National Security, Veterans Affairs and International Relations. April 29, 1999. “Anthrax Vaccine: Safety, Efficacy and Legality.” (Written and oral) http://www.anthraxvaccine.org/Testimonies.html
- Nass M. Letter. Safety of the smallpox vaccine among military recipients.
JAMA. 2003 ;290:2123-4.
- Nass M. Anthrax Vaccine: Caveat Emptor (Let the Buyer Beware). Current Treatment Options in Infectious Disease 2003;5:361-4.
- Nass M and Nicholson G. Anthrax Vaccine: Historical Review and Current Controversies. Journal of Nutritional and Environmental Medicine 2002; 12: 277-86. http://www.immed.org/publications/gulf_war_illness/2JNEM_Nass_Nicolson2002ss.html
- Nicholson GL, Berns P, Nasrall MY, Haier J, Nicholson NL and Nass M. Gulf War Illnesses: Chemical, Biological and Radiological Exposures Resulting in Chronic Fatiguing Illnesses Can be Identified and Treated. J Chronic Fatigue Syndrome 2003; 11:135-154. http://www.immed.org/publications/gulf_war_illness/netaGWI_JCFS.html
- Nass M. Author Reply. American Journal of Public Health 2002; 92: 1708-9. http://www.anthraxvaccine.org/CV/AJPH_letter_exchange.html
- Nass M. Anthrax Vaccine Not Safe and Effective (letter). Emergency Medicine News, July 2002; 24: 44. http://www.anthraxvaccine.org/emn.html
- Nass M. The Anthrax Vaccine Program, and an Analysis of the CDC’s Recommendations for Vaccine Use. American Journal of Public Health, 2002; 92: 715-21. http://www.anthraxvaccine.org/CV/AJPH_May2002.html
- Nass M. Who is Protecting the Public Health? Z Magazine, April 2002; 14: 7-10. http://www.zmag.org/ZMag/articles/april02nass.htm
- Nass M. Anthrax Threat is Real (letter). Technology Review, October 2001; 104: 2 MIT. http://www.anthraxvaccine.org/CV/Technology_Review_Letter.html
- Nicholson GL, Nass M, Nicholson NL. The Anthrax Vaccine Controversy—Questions about its Efficacy, Safety and Strategy. Medical Sentinel, 2000; 5: 97-101. http://www.haciendapub.com/article43.html
- Nicholson GL, Nass M, Nicholson NL. Anthrax Vaccine: Controversy Over Safety and Efficacy. Antimicrobics and Infectious Disease Newsletter, 2000; 18:1-6. http://www.immed.org/publications/gulf_war_illness/anthrax3-18-00.html
- Nass M. Should the Military Suspend Its Anthrax Vaccine Program? Physicians Weekly, June 19, 2000; 17:1.
- Nass M. The Anthrax Dilemma: Safety Issues Revisited. Medicine and Global Survival, 1999; 6: 54. http://www.ippnw.org/MGS/V6N1AnthraxUpdate.html
- Multiple Chemical Sensitivity: A 1999 Consensus. Archives of Environmental Health, 1999; 54, 147–149. http://www.scienceblog.com/community/older/1999/B/199901461.html
- Nass M. Biological Warfare and Vaccines: Anthrax. Applied Science and Analysis Newsletter, April 15, 1999: 10-11, continued in later issues.
- Nass M. Anthrax vaccine: Model of a response to the biological warfare threat. Infectious Disease Clinics of North America, 1999; 13: 187-208. http://www.anthraxvaccine.org/AVmodel.htm
- Sidel V, Nass M, Ensign T. The Anthrax Dilemma. Medicine and Global Survival, 1998; 5: 97-104. http://www.ippnw.org/MGS/V5N2Anthrax.html
- Nass M. Will anthrax vaccine help prevent biological warfare? Defense Systems International, Fall 1998. 35-39. (reprint of number 20). http://www.anthraxvaccine.org/CV/Defense_Systems_International.html
- Nass M. Biological Warfare (letter). The Lancet, 1998; 352: 491-2. http://www.anthraxvaccine.org/CV/Lancet_1998.html
- Nass M. Anthrax Vaccine and the Prevention of Biological Warfare? Applied Science and Analysis Newsletter, April 30, 1998: 1, 23-25, 32.
- Report of the Subgroup on Investigation of Alleged Use or Release of Biological or Toxin Weapons Agents. Federation of American Scientists Working Group on Biological Weapons Verification, April 1996. http://www.fas.org/bwc/papers/report.html
- Nass M. The Choice is Between Arms Control and Abolition. Medicine and Global Survival, 1995; 2: 180-181. http://www.ippnw.org/MGS/V2N3CWForum.html
- Nass M. Germ Warfare: Time Now for Verifiable Disarmament (Op-Ed). Interpress News Service (syndicated), March 1993.
- Nass M. Anthrax Epizootic in Zimbabwe 1978-1980: Due to Deliberate Spread? PSR Quarterly, 1992; 2: 198-209. http://www.anthraxvaccine.org/zimbabwe.html
- Nass M. Zimbabwe’s Anthrax Epidemic. Covert Action, 1992; 43: 12-18, 61.
- Nass M. Can Biological, Toxin, and Chemical Warfare Be Eliminated? Politics and the Life Sciences, 1992; 11: 30-32. http://www.anthraxvaccine.org/CV/Pol_Life_Sci_1992.html
- Nass M. Author reply. PSR Quarterly, 1991; 1: 230.
- Nass M. The Labyrinth of Biological Defense. PSR Quarterly, 1991; 1: 24-30.
- Nass M, Langford HG, Jackson JF, Parent AD. Acromegaly. Journal of the Mississippi State Medical Association, 1985; 26: 251-255.
- Zeitlin M, Masangkay M, Consolacion M, Nass M. Breastfeeding and Nutritional Status in Depressed Areas of Greater Manila, Phillippines. Ecology of Food and Nutrition, 1978; 7: 103-113.
- Grant CK, Adams EP, Nass M. Appearance of Cytolytic Antibodies in Sheep Lymph Following Immunisation with Tumour Cells: Identification of Antibody Subclasses. Australian Journal of Experimental Biology and Medical Science, 1976; 53: 381-387
- Portland Phoenix December 10-16, 2004 http://www.portlandphoenix.com/features/other_stories/multi1/documents/04318072.asp
- Brunswick Times Record. Page 1. October 12-14, 2001.
- Stars and Stripes. March, 2001
- Technology Review. Alumni section, page 16, November/December 2000
- Lewiston Sun-Journal. Page 1. March 13, 2000 (Associated Press)
- Brunswick Times Record. Page 1. March 13, 2000
- Portland Press Herald. Page 1. March 11, 2000
- Maine Times. Page 9. August 26, 1999
that have discussed Dr. Nass’ research and writing
The War Next Time: Countering Rogue States and Terrorists Armed with Chemical and Biological Weapons. Schneider BR and Davis JA, Eds. USAF Counterproliferation Center, Maxwell AFB, Alabama. (See Chapter 5: Pointing the Finger: Unclassified Methods to Identify Covert Biological Warfare Programs, by Dorothy L. DuBois.) 2004
Project Coast: Apartheid’s Chemical and Biological Warfare Programme. Gould C and Folb P. United Nations Publications (UNIDIR). 2002.
Anthrax: A Deadly Shot in the Dark. Thomas S. Heemstra. Crystal Communications. 2002.
Bio-terrorism: How to Survive the 25 Most Dangerous Biological Weapons. Pamela Weintraub. Citadel Press. 2002.
The Rollback of South Africa’s Biological Warfare Program. Stephen Burgess and Helen Purkitt. US Air Force Institute for National Security Studies. 2001.
Bioterrorism and Biocrimes. W. Seth Carus. Center for Couonterproliferation Research, National Defense University. 2001.
Anthrax, A Practical Guide for Citizens. The Parents Committee for Public Awareness. Harvard Perspectives Press. 2001.
Gulf War Syndrome, Legacy of a Perfect War. Alison Johnson. MCS Information Exchange. 2001
Immunization: History, Ethics, Law and Health. Catherine Diodati. Integral Aspects Incorporated. 2000.
Scientific Aspects of Control of Biological Weapons. The Royal Society. 1994.